Ask AI
ProCE Banner Activity

Selecting Treatment for HER2-Low/Ultralow mBC After Progression on ET

Slideset

Download these slides from an ASCO 2025 live satellite symposium on selecting treatment for HER2-low/ultralow metastatic breast cancer following progression on standard endocrine therapy. 

Released: May 22, 2025

Expiration: November 21, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.